Clinical Trial Update: A Second Study of Cytisinicline for Smoking Cessation in Adult Smokers [Phase 3]

View source ↗

Summary

This document reports the results of a second Phase 3 trial evaluating cytisinicline for smoking cessation in adult smokers, with results posted on January 14, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Drugs mentioned

• Cytisinicline

Snippet

Sponsor: Achieve Life Sciences | Conditions: Smoking Cessation | Phase 3 | Status: COMPLETED | Results posted: 2026-01-14